Skip to content

The effect of stellate ganglion block on postoperative anxiety in elderly patients undergoing abdominal surgery: A randomized controlled study

The effect of stellate ganglion block on postoperative anxiety in elderly patients undergoing abdominal surgery: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122453
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative anxiety

Interventions

Stellate Ganglion Block Group:SGB with 0.25% ropivacaine
Control Group:Only perform SGB scanning without performing the block.

Sponsors

Shandong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 65 years and above; 2. Planned to undergo elective abdominal surgery (stomach surgery, intestinal surgery, hepatobiliary surgery, pancreatic surgery, or appendectomy), with an expected operative time of 1 to 6 hours; 3. ASA physical status Class 1-3.

Exclusion criteria

Exclusion criteria: 1. Underwent abdominal surgery in the past 6 months; 2. Patients with preoperative anxiety (HADS-A > 7 points); 3. Body mass index (BMI) > 30; 4. Presence of contraindications to general anesthesia or nerve block, such as coagulation disorders, local and systemic infections, etc.; 5. Previously received SGB treatment; 6. Patients with a history of stroke or diagnosed with other central nervous system diseases within the past 6 months; 7. Patients with a history of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, or other psychiatric disorders; 8. History of brain injury or functional neurosurgery; 9. History of sinus syndrome, bradycardia (heart rate 442 µmol/L / requiring renal replacement therapy or liver dysfunction [Child-Pugh class C]); 11. Patients with alcohol abuse or a history of dependence on psychiatric drugs; 12. Complicated with metabolic disorders related to cortisol excess/deficiency; 13. Patients unable to communicate due to severe visual, hearing, or speech problems; 14. Considered by the investigator as unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative anxiety on POD1;

Secondary

MeasureTime frame
Postoperative anxiety on POD3;Postoperative depression;Postoperative sleep disorder;Postoperative recovery quality;Intraoperative hemodynamics;VAS pain score;Perioperative analgesic drug consumption;Hospital stays;

Countries

China

Contacts

Public ContactYaozhu Wang

Shandong Second Provincial Hospital

wyz1990411788@163.com+86 183 5317 2500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026